Washington Times News + 1 source

FDA Approves Merck’s Lipfendra, First Daily Pill to Drastically Lower Cholesterol

The FDA has authorized a novel oral medication that significantly reduces LDL cholesterol in high-risk patients, offering an alternative to costly injectable treatments.